Anzeige
Mehr »
Mittwoch, 17.09.2025 - Börsentäglich über 12.000 News
Die Ethereum-Vorreiter: Wie Republic Technologies die Infrastruktur der Zukunft aufbaut
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
394 Leser
Artikel bewerten:
(2)

Frost & Sullivan recognizes Change Healthcare with the 2021 North America Customer Value Leadership Award for Clinical Decision Support

Change Healthcare's CDS solutions improve efficiencies, lower unnecessary costly interventions, and deliver measurable positive outcomes, driving customer trust and a high growth rate

SANTA CLARA, Calif., Sept. 28, 2021 /PRNewswire/ -- Based on its recent analysis of the North American clinical decision support system (CDSS) market, Frost & Sullivan recognizes Change Healthcare with the 2021 North America Customer Value Leadership Award. Its CDSS InterQual and CareSelect solutions provide self-built and third-party, evidence-based guidelines that aid providers and payers in decision-making. Powered by advanced technology combining predictive analytics, machine learning, robotic process automation and natural language processing, its CDSS leverages artificial intelligence to advance value-based care and improve payer-provider communications.

"Change Healthcare's CDSS validates care and order appropriateness, drives cost- and resource-optimized clinical decisions, and standardizes and streamlines care decision workflows. It integrates clinical criteria, electronic health records data, and the care management system's foundation to ensure seamless payer and provider connectivity," said Unmesh Lal, Director at Frost & Sullivan. "Essentially, Change Healthcare advances value-based care with improved customer satisfaction by providing measurable positive outcomes such as reduced utilization, appropriate patient placement and services, shorter length-of-stay, and lower administrative costs."

The company's flagship InterQual solution is easily accessible by clinicians within existing workflows. It employs an evidence-based content development process involving a team of 60 clinicians performing a rigorous literature review and a panel of over 1,000 expert peer reviewers. Over 3,000 sites are monitored with a proprietary analytics tool to alert the team as soon as new literature is published. The InterQual transparency solution can be hosted on the payer organization's provider and member portals and enables members and providers to view the content used for authorization.

Change Healthcare is transforming utilization management by combining artificial intelligence and automation with this evidence-based criteria to help remove administrative burden and payer-provider friction. InterQual AutoReview uses robotic process automation to complete the medical review and layers in predictive analytics to provide early insights for level of care placement, length of stay management and discharge preparation. InterQual Connect enables the automation of prior authorizations requiring clinical data submission, streamling the process for payers and providers and speeding care for patients.

Meanwhile, the CareSelect solution enables providers to access CDS on-demand at the right time and setting. It seamlessly harnesses the clinical workflow to extract targeted information from installed leading EHR systems. The CareSelect Imaging solution, a CMS Qualified Decision Support Mechanism, enhances imaging appropriateness within existing EHR, ordering workflow in compliance with the Protecting Access to Medicare Act (PAMA) while the CareSelect Lab solution reduces unnecessary lab test utilization to decrease costs, raise care quality, and control financial risks. Its other solutions include CareSelect Blood and CareSelect Risk Assessor to assess the probability of breast cancer.

"With an extensive client base, Change Healthcare's clinical decision support system services more than 4,000 provider facilities, over 1,000 health systems, across 3,400 acute hospitals, representing nearly 70% of admissions. It facilitates more than 150 million annual transactions and is now expanding adoption beyond acute care facilities to other sites of care," noted Supriya Lala, Best Practices Research Analyst at Frost & Sullivan. "By improving efficiencies and delivering measurable outcomes, Change Healthcare's CDSS is expected to continue improving customer relations and drive long-term business growth."

Each year, Frost & Sullivan presents this award to the company that demonstrates excellence in implementing strategies that proactively create value for its customers, focusing on improving the return on the customers' investment in its services or products. The award recognizes the company's unique focus on augmenting the value that its customers receive, beyond simply good customer service, leading to improved customer retention and customer base expansion.

Frost & Sullivan Best Practices awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analyses, and extensive secondary research to identify best practices in the industry.

About Frost & Sullivan

For six decades, Frost & Sullivan has been world-renowned for its role in helping investors, corporate leaders, and governments navigate economic changes and identify disruptive technologies, Mega Trends, new business models, and companies to action, resulting in a continuous flow of growth opportunities to drive future success. Contact us: Start the discussion.

Contact:
Kristen Moore
P: 210.247.3823
E: kristen.moore@frost.com

© 2021 PR Newswire
Epische Goldpreisrallye
Der Goldpreis hat ein neues Rekordhoch überschritten. Die Marke von 3.500 US-Dollar ist gefallen, und selbst 4.000 US-Dollar erscheinen nur noch als Zwischenziel.

Die Rallye wird von mehreren Faktoren gleichzeitig getrieben:
  • · massive Käufe durch Noten- und Zentralbanken
  • · Kapitalflucht in sichere Häfen
  • · hohe Nachfrage nach physisch besicherten Gold-ETFs
  • · geopolitische Unsicherheit und Inflationssorgen

Die Aktienkurse vieler Goldproduzenten und Explorer sind in den vergangenen Wochen regelrecht explodiert.

Doch es gibt noch Titel, die Nachholpotenzial besitzen. In unserem kostenlosen Spezialreport erfahren Sie, welche 3 Goldaktien jetzt besonders aussichtsreich sind und warum der Aufwärtstrend noch lange nicht vorbei sein dürfte.

Laden Sie jetzt den Spezialreport kostenlos herunter und profitieren Sie von der historischen Gold-Hausse.

Dieses Angebot gilt nur für kurze Zeit – also nicht zögern, jetzt sichern!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.